Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otrivin F2 for nasal congestion associated with common cold
2006-006690-25Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nasopharyngitis comparing Otrivin F2 with Placebo (2 arms). Primary endpoint: Upper airway conductance at 1 hour. Started Jan 2007; status: completed.
02
Drugs
xylometazoline
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2006-006690-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006690-25.